Primary nasal-type natural killer/T-cell lymphoma of the testis is a rare malignancy. Although dissemination to the testis from other sites occurs somewhat more frequently than a primary presentation, even secondary testicular involvement is uncommon. In this article, the authors report on the comprehensive histopathologic, immunohistochemical, and molecular analysis of a case of primary testicular nasal-type natural killer/T-cell lymphoma, and review the features of 16 previously reported patients. The investigation carried out in this study indicates that the testicular nasal-type natural killer/T-cell lymphomas occur at a younger age than their B-cell counterparts, express cytoplasmic CD3 and surface CD56, and consistently show an infection by Epstein-Barr virus. These tumors have variable expression of T-cell antigens other than cytoplasmic CD3 and may show monoclonal rearrangement of T-cell receptor genes. Testicular natural killer/T-cell lymphomas of nasal type invariably follow an aggressive clinical course.
Chan J., Jaffe E., Ralfkiaer E.Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe E, Harris N, Stein H, Vardiman J, eds. World Health Organization classification of tumours: tumours of the haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001:204-207.
2.
Ko Y., Cho E-Y., Kim J-E., et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology. 2004;44:480-489.
3.
Ohsawa M., Nakatsuka S-I., Kanno H., et al. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. Int J Cancer. 1999;81:865-870.
4.
Chiang A., Chan A., Srivastava G., Ho F.Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NKand T-cell lineage. Int J Cancer. 1997;73:332-338.
5.
Ng S., Lai K., Murugaya S., et al. Nasal-type extranodal natural killer/T-cell lymphomas: A clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17:1097-1107.
6.
Siu L., Chan J., Kwong Y.Natural killer cell malignancies: clinicopathologic and molecular features . Histol Histopathol. 2002;17:539-554.
7.
Khouri I., Romaguera J., Kantarjian H., et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma . J Clin Oncol. 1998;16: 3803-3809.
8.
McNiff J. , Cooper D., Howe G., et al. Lymphomatoid granulomatosis of the skin and lung: an angiocentric T-cell-rich B-cell lymphoproliferative disorder . Arch dermatol. 1996;132:1464-1470.
9.
Shadrach B., Warshawsky I.A comparison of multiplex and monoplex T-cell receptor gamma PCR. Diagn Mol Pathol. 2004;13:127-134.
10.
Ballereau C. , Leroy X., Morschhauser F., et al. Testicular natural killer T-cell lymphoma . Int J Urol. 2005;12: 223-224.
11.
Wright C., Cooper K., Geiman G., Davidge-Pitts M.Natural killer cell lymphoma in cytology: breaking all the rules-a case report . Diagn Cytopathol. 1998;19:9-11.
12.
Castex M., Bertozzi A., Rubie H., et al. Testicular feminization syndrome, germinal tumour, NK cell lymphoma: what is the relationship?Arch Pediatr. 2001 ;8:1337-1340.
13.
Perez-Valles A., Sabater-Marco V., Carpio-Manez D., Botella-Estrada R., Nogueira-Vazquez E., Martorell-Cebollada M.Extranodal peripheral T-cell lymphoma with angiocentric growth pattern and Epstein-Barr viral DNA associated affecting paratesticular soft tissue. J Cutan Pathol. 2000;27:80-85.
14.
Scolnik M., Burgos R., Paz A., et al. Nonhepatosplenic γδ T-cell lymphoma with initial testicular compromise. Am J Hematol. 2000;65:260-262.
15.
Bartolome J. , Gonzalez-Arenas M., Menarguez J., Gil J.Nasal type T/NK cell lymphoma with testicular presentation. Med Clin (Barc) . 2000;114:318.
16.
Chan J., Tsang W., Lau W., et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer. 1996;77:1198-1205.
17.
Chan J., Sin V., Wong K., et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm . Blood. 1997;89:4501-4513.
18.
Guler G., Altinok G., Uner A., Sungur A.CD56+ lymphoma presenting as a testicular tumor. Leuk Lymphoma . 1999;36:207-211.
19.
Kim Y., Chang S., Yang W-I., et al. Primary NK/T cell lymphoma of the testis. A case report and review of the literature. Acta Haematol. 2003 ;109:95-100.
20.
Kurpis M., Diller A., Calafat P., Ruiz Lascano A.Extranodal NK/T cell lymphoma of the nasal type. Rev Fac Cien Med Univ Nac Cordoba. 2002;59:117-120.
21.
Sun T., Brody J., Susin M., et al. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity. Am J Surg Pathol.1993;17:1289-1299.
22.
Totonchi K. , Engel G., Weisenberg E., Rhone D., Macon W.Testicular natural killer/t-cell lymphoma, nasal type, of true natural killer-cell origin. Arch Pathol Lab Med. 2002;126:1527-1529.
23.
Nieto M., Rodriguez-Fernandez J., Navarro F., et al. Signaling through CD43 induces natural killer cell activation, chemokine release and PYK-2 activation. Blood. 1999;94:2767-2777.
Kern W., Spier C., Hanneman E., Miller T., Matzner M., Grogan T.Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992;80:2431-2432.
26.
Goridis C., Brunet J.NCAM: Structural diversity, function and regulation of expression . Semin Cell Biol. 1992; 3:189-197.
27.
Mayerhofer A., Lahr G., Seidl K., Eusterschulte B., Christoph A., Gratzl M.The neural cell adhesion molecule (NCAM) provides clues to the development of testicular Leydig cells. J Androl . 1996;17:223-230.
28.
Orth J., Jester Jr W.NCAM mediates adhesion between gonocytes and Sertoli cells in cocultures from testes of neonatal rats. J Androl. 1995 ;16:389-399.
29.
Aguado E., Santamaria M., Gallego M., Pena J., Molina I.Functional expression of CD43 on human natural killer cells. J Leukoc Biol. 1999;66:923-929.
30.
Kulahin N., Rudenko O., Kiselyov V., Poulsen F., Berezin V., Bock E.Modulation of the homophilic interaction between the first and second Ig modules of neural cell adhesion molecule by heparin. J Neurochem. 2005;95:46-55.
31.
Klerk C., Smorenburg S., Otten H., et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol. 2005 ;23:2130-2135.
